On behalf of the Scientific Program Planning Committee and PDA Europe, we are proud to present the 2021 PDA Annex 1 Conference to take place in Dublin, Ireland on 8-9 June 2021!
We would like to invite you to submit a paper or poster abstract for presentation. Abstracts must be non-commercial in nature, describing new developments or work that significantly contributes to the body of knowledge relating to the new Annex 1.
The conference will take place as a Hybrid Event with an online platform allowing for remote participation and presentation in support of the on-site event!
The long-awaited draft of the revised Annex 1 was released for discussion last year and now the final revision is anticipated later this year. The document’s focus and content has changed significantly, and the industry is eager to see how these changes will result in new requirements, inspection expectations, and overall process control strategies. Clarification on the intent of new and existing requirements is anticipated. This conference will cover the impact on the industry and on manufactures. Local authorities and industry speakers representing medicines and vaccines manufacturers, as well as equipment and instrumentation suppliers, will present their views on the revised Annex 1 and the modifications it induces. Sufficient time has been allocated to discuss how to address the new requirements and be proactive in getting ready to comply with the new regulation.
The hybrid format will allow for the convenient participation of experts from all over the world and will facilitate the interaction with the speakers in the Q&A sessions.
We look forward to you joining us in Dublin next Summer!
Gabriele Gori, GSK
Hal Baseman, ValSource
SCIENTIFIC PROGRAM PLANNING COMMITTEE
Gabriele Gori, GSK, Chair
Hal Baseman, ValSource, Chair
Darren Beckett, Sterility Solutions
John Henchion, CAI
Andrew Hopkins, Abbvie
Brid Lynch, J&J
Janie Miller, PDA
Falk Klar, PDA Europe
Sylvia Becker, PDA Europe Senior Manager Programs & Events